Skip to main content
. 2016 Feb 12;7(11):12904–12916. doi: 10.18632/oncotarget.7354

Table 3. Variations of the mean intensities of the most relevant metabolites involved in the discrimination between BPD patients and healthy individuals or NSCLC patients.

Metabolites δ1H (ppm)a BPD vs. Healthy BPD vs. NSCLC
% variation P-valueb % variation P-valueb
HDL (CH3) 0.85-0.79 −6.55 0.3602 −9.37 0.1073
VLDL (CH3) 0.91-0.85 −0.19 0.7539 −16.47 0.0002*
Leucine/Isoleucine 0.97-0.91 2.52 0.9319 8.54 0.0360*
3-hydroxybutyrate 1.20-1.18 −2.98 0.5490 20.64 0.0735
LDL/VLDL (CH2)n 1.31-1.20 1.61 0.9319 −23.28 0.0000*
Unknown 1 1.40-1.36 34.21 0.1424 −7.80 0.0676
Adipic acid 1.60-1.52 4.30 0.8867 −28.57 0.0001*
Acetate 1.91-1.90 −15.53 0.7979 6.96 0.0078*
Lipids (CH2-C=C) 2.02-1.93 −6.28 0.1424 −15.00 0.0000*
N-Acetyl-cysteine 2.05-2.02 −8.02 0.0392* −6.80 0.0152*
Lipids (CH2-CO) 2.26-2.19 4.63 0.8867 −12.33 0.1674
Glutamate 2.36-2.33 −7.84 0.2175 43.35 0.0000*
Glutamine 2.47-2.41 −15.34 0.1065 −14.08 0.0136*
Lipids (CH=CH-CH2-CH=CH) 2.79-2.68 −0.06 0.6077 −15.40 0.0000*
Choline –N(CH3)3+ 3.21-3.18 −3.46 0.8197 −14.45 0.0461*
Proline 3.30-3.34 −27.10 0.0130* −15.46 0.0434*
Methanol 3.36-3.35 −45.45 0.0010* −34.12 0.0002*
Unknown 2 3.55-3.54 −10.03 0.3166 17.93 0.0091*
Unknown 3 3.58-3.56 −13.86 0.2765 9.10 0.1714
Valine 3.61-3.59 −11.64 0.2068 9.14 0.2150
Glycerol 3.80-3.78 −7.20 0.4406 17.94 0.0027*
Creatine 3.92-3.91 −12.39 0.2175 22.52 0.0005*
Creatinine 4.04-4.03 −0.24 0.6898 −24.18 0.0000*
Myo-inositol 4.07-4.05 10.28 0.4578 −33.58 0.0000*
Lactate 4.13-4.08 49.44 0.0002* 16.92 0.0136*
Threonine 4.30-4.21 4.85 0.5878 −26.09 0.0000*
Glucose 5.24-5.21 −5.59 0.2639 42.78 0.0000*
Lipids (CH=CH) 5.37-5.24 2.23 0.3602 −21.01 0.0000*
a

Chemical shift region used for quantification

b

P-value calculated using the Mann–Whitney U test

*

Statistically significant (P < 0.05)